Several AMPs have been tested in vitro for their efficiency in antimicrobial activity, but their application in vivo is limited because of their toxicity to eukaryotic cells, susceptibility to proteolytic degradation, and the development of allergies [42,43]. This evidence concerns the gene ADSL and Allergy.